Skip to main content
Top

Clinical and Translational Oncology

Issue 7/2018

Content (17 Articles)

Editorial

New wind for the Spanish Federation of Scientific Oncological Societies (FESEO)

S. González-Moreno, Santiago González-Moreno, Pedro Carlos Lara, Jesús Mª Paramio, Encarna González-Flores, Ruth Vera, Jose Ignacio Chacón, A. Rodríguez-Lescure, Carlos Camps, Carlos J. Ferrer, Ana Fernández-Teijeiro, Jacobo Cabañas

Review Article

Morphine: double-faced roles in the regulation of tumor development

XY. Zhang, YX. Liang, Y. Yan, Z. Dai, HC. Chu

Open Access Review Article

Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

R. Colomer, I. Aranda-López, J. Albanell, T. García-Caballero, E. Ciruelos, M. Á. López-García, J. Cortés, F. Rojo, M. Martín, J. Palacios-Calvo

Review Article

Clinical implications of the deregulated TP73 isoforms expression in cancer

N. Rodríguez, A. Peláez, R. Barderas, G. Domínguez

Open Access Special Article

SEOM–SERAM–SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer

G. Fernández-Pérez, R. Sánchez-Escribano, A. M. García-Vicente, A. Luna-Alcalá, J. Ceballos-Viro, R. C. Delgado-Bolton, J. C. Vilanova-Busquets, P. Sánchez-Rovira, M. P. Fierro-Alanis, R. García-Figueiras, J. E. Alés-Martínez

Research Article

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice

I. Blancas, M. Fontanillas, V. Conde, J. Lao, E. Martínez, M. J. Sotelo, A. Jaen, J. L. Bayo, F. Carabantes, J. J. Illarramendi, M. M. Gordon, J. Cruz, A. García-Palomo, C. Mendiola, E. Pérez-Ruiz, J. S. Bofill, J. M. Baena-Cañada, N. M. Jáñez, G. Esquerdo, M. Ruiz-Borrego

Research Article

Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer

M. Saigi, A. McLeer-Florin, E. Pros, E. Nadal, E. Brambilla, M. Sanchez-Cespedes

Research Article

Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma

H. Luo, Y. Y. Cui, J. G. Zhang, Y. N. Sun, X. L. Zheng, C. L. Yang, K. Ye, H. Ge

Research Article

Curative radiation therapy for very elderly bladder cancer patients with localized disease

M. Bonet, T. Bonfill, M. Nuñez, L. De Verdonces, E. Mur, E. Gallardo, L. Fernandez-Morales, A. Aguilar, J. Prats, M. Arenas

Research Article

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients

M. Wang, S. Ji, G. Shao, J. Zhang, K. Zhao, Z. Wang, A. Wu

Research Article

The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study

L. Yang, Z. Lv, W. Xia, W. Zhang, Y. Xin, H. Yuan, Y. Chen, X. Hu, Y. Lv, Q. Xu, X. Weng, C. Ni

Research Article

Bevacizumab for recurrent, persistent or advanced cervical cancer: reproducibility of GOG 240 study results in “real world” patients

A. Godoy-Ortiz, Y. Plata, J. Alcaide, A. Galeote, B. Pajares, E. Saez, E. Alba, A. Sánchez-Muñoz

Open Access Brief Research Article

Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature

X. Zhang, D.-S. Liu, Z.-S. Luan, F. Zhang, X.-H. Liu, W. Zhou, S.-F. Zhong, H. Lai

Correction

Correction to: Curative radiation therapy for very elderly bladder cancer patients with localized disease

M. Bonet, T. Bonfill, M. Nuñez, L. De Verdonces, E. Mur, E. Gallardo, L. Fernandez-Morales, A. Aguilar, J. Prats, M. Arenas

Correction

Correction to: SEOM clinical guidelines for anaplastic gliomas (2017)

C. Balañá, M. Alonso, A. Hernandez-Lain, P. Perez-Segura, E. Pineda, A. Ramos, A. R. Sanchez, P. Teixidor, E. Verger, M. Benavides

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine